Mynd.ai, Inc ("Mynd" or the Company) (NYSE American: MYND) through its subsidiary, Promethean, a leading global ...

GoodRx , the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more widely available. First, the launch of GoodRx for ...